How much does a market diagnostic cost?

A paid market-entry diagnostic currently ranges from ¥300,000 to ¥500,000 depending on category, direction, and data access. The diagnostic delivers a readiness scorecard, demand and competitor review, localization gap analysis, compliance register, and a 90-day execution roadmap.

How long does the diagnostic take?

The diagnostic phase is designed to be completed in 2–4 weeks. At the end, you receive a commercial and operating assessment with a clear go, conditional-go, or no-go recommendation for the next stage.

What happens after the diagnostic?

If both parties agree to proceed, we move into a managed monthly engagement focused on one commercial objective and up to three primary workstreams. You retain full control over campaign budgets — media spend is paid directly to platforms.

Can I stop after any stage?

Yes. Each stage has a clear decision gate. After the fit call you can decide not to proceed. After the diagnostic you receive a recommendation but the decision is yours. The monthly engagement is reviewed at agreed intervals with a continue, pause, or expand decision.

Our process

Three stageswith decision gates

Each stage has a defined scope, deliverables, and a decision to continue, pause, or stop.

Fit Call

30 minutes

We review your target market, offer, operating readiness, budget ownership, and decision timeline to confirm mutual fit.

Business and target-market review

Readiness risks

Mutual go or no-go decision

Market Diagnostic

2–4 weeks · ¥300K–¥500K

We examine demand, competition, channel economics, localization gaps, conversion paths, and operational constraints before execution.

Demand and competitor review

Channel priorities

Localization and conversion gaps

90-day execution roadmap

Managed Engagement

Monthly · ¥800K–¥1.5M

We execute the approved roadmap, review evidence, and make bounded monthly decisions without guaranteeing outcomes.

Prioritized execution workstreams

Localized content and campaigns

Measurement review

Continue, pause, or expand decision

Framework credibility

Built from real cross-border work

Our methodology is grounded in diagnosed campaigns and measured outcomes, not theory.

30+Cross-border campaigns diagnosed

5+Japan–Korea market-entry frameworks developed

12+Categories evaluated across beauty, medical, and CPG

¥1B+Aggregate cross-border media spend analyzed

Readiness simulation

What a diagnostic scorecard evaluates

A Medical Beauty clinic entering Japan — sample readiness dimensions reviewed during a Market Diagnostic.

Demand validation — is there active search and conversion intent in Japan?
Channel readiness — does the current operation support Japanese customer acquisition?
Localization depth — are landing pages, consultations, and consent processes Japan-ready?
Regulatory posture — medical device / cosmetic compliance for target services

Japan Readiness Scorecard (sample)Medical Beauty · 90-day view

Demand

Consistent organic search from JP

High

Channel

LINE OA active, no paid strategy

Medium

Localization

EN landing only, no JP consent flow

Low

Compliance

Device registration pending

Medium

Sample output — actual diagnostic results vary by client, category, and market conditions.

Operating principles

What governs the work

Clear ownership, evidence, and constraints matter more than inflated promises.

No fabricated claims

We do not publish unverified ROAS, client counts, retention rates, or guaranteed outcomes.

Ad spend separation

Media spend is paid directly to platforms and remains separate from professional fees.

Defined ownership

Approvals, regulatory review, inventory, sales, and customer support owners are identified before launch.

Decision gates

Evidence is reviewed at agreed intervals before work is continued, paused, or expanded.

Frequently asked questions about the process

Start with fit

Share your current situation and we will tell you whether a diagnostic is the responsible next step.